
Since 1990 a concerted action between European zzso cancer zzso (the zzso zzso has been carried out with the aims of establishing whether there are differences in cancer patient survival in Europe, and the reasons for such zzso Survival differences actually exist for cancer sites for which the stage of disease at diagnosis is the major zzso factor (such as breast, stomach and colon zzso However, for most cancer sites, survival increases over time and the survival rates of different countries tend to zzso towards higher zzso Interpreting survival differences and trends is not an easy zzso zzso survival may be achieved by zzso death through better treatment or by anticipating zzso However, an earlier diagnosis may or may not make a treatment more effective in zzso zzso The zzso of zzso or zzso survival is not sufficient for interpretation of survival differences, because staging procedures change over time and may vary in different hospitals and zzso In addition to an early diagnosis and more effective treatment, a number of factors may bias survival zzso They may be classified into factors that can be controlled in the analysis (at least zzso such as mortality from other causes, demographic factors, zzso of diagnosis, different statistical methodology, and factors depending on the zzso of cancer registry data, such as definition of the illness, zzso and quality of zzso zzso of zzso definition of the data of diagnosis, and definition of disease stage including the diagnostic procedure used to establish zzso To help zzso the effects of early diagnosis and better treatment, several statistical approaches are being developed: zzso analysis on relative survival data, new modeling analysis to separately estimate the proportion of cured patients and the length of survival for those patients destined to die, and the standardized collection of information on stage at diagnosis and staging zzso 

